Posts

Cold Chain in Vaccine Rollout: from COVID-19 Pandemic Perspective

Image
 It had been a year since the Novel Corona Virus (COVID-19) outbreak happened. Scientists had continuously strived to invent a vaccine, and finally, many pharmaceutical companies are coming up with their interventions. With the few of the clinical trials coming to a climax, the Pharma companies and Governments are pondering on the distribution of vaccines to billions of people and their supply chain management which poses as one of the major challenges. From the time of manufacture till distribution, vaccines must be continuously stored in a limited temperature range, according to the type of vaccine. Different vaccines have different storage conditions like ambient, freeze-sensitive or frozen. Since vaccines are parenteral, optimal temperature and storage are to be taken care of to prevent any leakage and decrease in the efficacy of the vaccine. In order to tackle this challenge, WHO has recommended certain ‘cold chain’ principles to manage the vaccine roll out? A temperature-controll

Effect of Lockdown on Clinical Trials

The pandemic lockdown and quarantine has slowed down or in some cases paused most of our everyday lives. With daily routines affected, there is a butterfly the effect that ended up affecting most professions in some or the other way- including the clinical research industry.                                   With the whole world focusing on COVID19 research , much of non-COVID19 related ongoing and upcoming projects have taken a backseat – especially, in-person operations. This doesn’t necessarily mean a complete halt in the research process, regulatory bodies like USFDA have issued guidelines on conduct of clinical trials during COVID-19 pandemic. Although these guidelines are designed to tackle current pandemic, these changes are bound to have short term implications that could potentially shift the way in which the industry functions in the long term. Effects on research operations/procedures/ trial progress: Trial sites that have been transformed or dedicated for CO